XRCC4 and glioma: Mechanically, X-ray cross-complementing gene 4 (XRCC4) was directly targeted by miR-151a, and the repression of miR-151a elevated XRCC4 levels, activating DNA repair and increasing the resistance of glioma to TMZ (41).